Influence of different CyA formulations and calcium channel blocker phenyhidine regimens on intracellular (erythrocyte) calcium levels after kidney transplantation.
Adamsone
I
I
Department of Transplantation, Medical Academy of Latvia, Riga, Latvia.
Babarykin
D
D
Amerika
D
D
Bicans
J
J
Rosental
R
R
Pettersson
E
E
D000284:Administration, Oral; D001379:Azathioprine / Q000627:therapeutic use; D002118:Calcium / Q000097:blood*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004304:Dosage Forms; D004347:Drug Interactions; D004655:Emulsions; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D011239:Prednisolone / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D002118:Calcium